epibatidine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gillespie, A; K Lloyd, G; Langston, JW; Polonskaya, Y; Quik, M | 1 |
Kulak, JM; McIntosh, JM; Polonskaya, Y; Quik, M | 2 |
Kulak, JM; McIntosh, JM; Quik, M | 1 |
Bottlaender, M; Coulon, C; Dannals, RF; Dolle, F; Kassiou, M; Loc'h, C; Maziere, B; Musachio, JL; Ottaviani, M | 1 |
Fan, H; Lai, A; McIntosh, JM; Quik, M; Sum, J | 1 |
Bordia, T; Clementi, F; Fan, H; Gotti, C; Kulak, JM; McIntosh, JM; Quik, M; Vailati, S | 1 |
7 other study(ies) available for epibatidine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Bungarotoxins; Caudate Nucleus; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Nerve Degeneration; Neurons; Nicotinic Agonists; Protein Isoforms; Putamen; Pyridines; Receptors, Nicotinic; RNA, Messenger; Saimiri; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |
Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cocaine; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Habenula; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Neural Pathways; Neurons; Parkinson Disease, Secondary; Putamen; Pyridines; Receptors, Nicotinic; Saimiri; Substantia Nigra | 2001 |
Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Caudate Nucleus; Conotoxins; Corpus Striatum; Dopamine Agents; In Vitro Techniques; Iodine Radioisotopes; Motor Activity; Nicotinic Agonists; Putamen; Pyridines; Radioligand Assay; Receptors, Nicotinic; Saimiri | 2002 |
Differential nicotinic receptor expression in monkey basal ganglia: effects of nigrostriatal damage.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkaloids; Animals; Azocines; Basal Ganglia; Brain Diseases; Bridged Bicyclo Compounds, Heterocyclic; Caudate Nucleus; Conotoxins; Corpus Striatum; Dopamine Agents; Female; Male; Nicotinic Agonists; Nicotinic Antagonists; Putamen; Pyridines; Quinolizines; Receptors, Nicotinic; Reference Values; Saimiri; Substantia Nigra; Tissue Distribution | 2002 |
Pharmacological evaluation of a Br-76 analog of epibatidine: a potent ligand for studying brain nicotinic acetylcholine receptors.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkaloids; Animals; Autoradiography; Azocines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Dopamine Agents; Ellipticines; In Vitro Techniques; Male; Nicotine; Nicotinic Agonists; Pyridines; Quinolizines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Nicotinic; Time Factors; Tomography, Emission-Computed | 2002 |
Selective recovery of striatal 125I-alpha-conotoxinmii nicotinic receptors after nigrostriatal damage in monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Female; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neural Pathways; Parkinsonian Disorders; Presynaptic Terminals; Pyridines; Receptors, Nicotinic; Recovery of Function; Saimiri; Substantia Nigra; Up-Regulation | 2004 |
Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alkaloids; Amino Acid Sequence; Animals; Antibodies; Autoradiography; Azocines; Brain; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cerebral Cortex; Corpus Striatum; Humans; Iodine Radioisotopes; Levodopa; Molecular Sequence Data; Nicotine; Protein Subunits; Pyridines; Quinolizines; Receptors, Nicotinic; Saimiri | 2005 |